media – Page 542 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Boosted by China launch, Merck’s Gardasil turns in a big first-quarter performance

Merck generated more than $1.5 billion in first-quarter vaccine sales. (Merck)
- Source: fiercepharma
- 592
- May 9, 2018
Gardasil HPV vaccine Merck
First-line use of Roche’s Tecentriq given priority review

US regulators are undertaking a priority review of Roche unit Genentech’s PD-L1 inhibitor Tecentriq, in combination with Avastin and standard chemotherapy for some patients with lung cancer.
- Source: pharmatimes
- 636
- May 9, 2018
Chemotherapy lung cancer Roche Tecentriq
Lyra Health raised $45 million to improve digital behavioral health technology, to treat mental illness

Today, Digital behavioral health company, Lyra Health announced that it has raised $45 million in Series B funding in a new financing round including Tenaya Capital, Glynn Capital, Crown Ventures, and Casdin Capital, as well as returning funders Greylock Partners, Venrock, and Providence Ventures.
- Source: drugdu
- 536
- May 8, 2018
AI Company Insights Mental health
Mobile-Health applications and wearables, to improve medication Adherence

Consumers are depending on mHealth applications and wearable devices to improve their medication abidance.
- Source: Ddu
- 801
- May 8, 2018
digital health Market Views mHealth
Fitbit unveils 8 applications for Ionic and Versa

A Fitbit official disclosed eight mobile health apps, including two focused on diabetes management and one on oncology care.
- Source: drugdu
- 956
- May 8, 2018
Company Insights Fitbit mHealth
Fitbit partners with Google digital health innovation

During the Fitbit Q1 earnings call, the company confirmed its focus on digital health regardless of the expected decline in sales numbers. Currently, Fitbit is focusing on its new alliance with Google, wherein the two companies will work together to speed up innovation in the digital health space to provide clear EHRs and precise patient data to help the clinicians.
- Source: Ddu
- 1,069
- May 8, 2018
Company Insights Market Views mHealth
Drugdu.com Launches Digital Marketing Strategy Solution for Pharmaceuticals and Medical Devices at CMEF Shanghai 2018

Drugdu.com presents their digital marketing strategy for the pharmaceutical and medical device industry and launches the Ddu Trade Accelerator to assist suppliers in expanding international business opportunities.
- Source: drugdu
- 2,546
- May 8, 2018
Exhibitions and Activities
New Oncology Clinical Collaboration between Nektar and Takeda to Evaluate Combination of NKTR-214, a CD122-biased Agonist, and TAK-659, a Dual SYK and FLT-3 Inhibitor, in Liquid and Solid Tumors

New collaboration to explore the potential clinical benefits of two novel and complementary immuno-oncology mechanisms
- Source: prnewswire
- 681
- May 8, 2018
multiple cancer TAK-659 Takeda
FDA Approves CAR T Therapy for Large B-Cell Lymphoma Developed at University of Pennsylvania

Nation’s first approved personalized cellular therapy now available for second indication
- Source: pennmedicine.org
- 541
- May 8, 2018
B-cell lymphoma FDA Kymriah
Privately-held Manipal increases bid for Fortis for INR 8358 Cr.

In a bid to sweeten its deal for Fortis Healthcare, Manipal Health Enterprises has proposed merging of both enterprises that pegs the value of the beleaguered Fortis at Rs. 8,358 crores. The buyout efforts of Manipal have been backed by US private equity firm TPG.
- Source: Ddu
- 546
- May 8, 2018
healthcare India Market Views

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.